Meningococcal vaccine market primed for growth; Biothera wins NIH grant for fungal vaccine;

> The global meningococcal vaccines market is set to grow at a CAGR of 15% by 2018, a new reports says. More

> The NIH has awarded Minnesota-based Biothera a $150,000 research grant for fungal vaccine development. Release

> Cancer vaccine maker OncoPep Inc. has raised $6.9 million in Series B financing from new and existing investors. Release

> Madison Vaccines' lead product candidate will be used in a clinical trial testing a two-pronged immunotherapy approach to treat metastatic prostate cancer. Release


And Finally... Sekunjalo Investment Holdings and Genius Biotherapeutics have partnered to develop therapeutic vaccines for cancer in South Africa. Report